icotec

icotec is a specialized, privately-held medical device company and a global market leader in non-metallic spinal implants for oncology. Its proprietary BlackArmor® Carbon/PEEK technology platform addresses critical limitations of traditional titanium implants by being radiolucent, which allows for unhindered radiation therapy (including proton therapy) and superior MRI/CT imaging for follow-up. With a commercial portfolio of pedicle screw, vertebral body replacement, and cervical plate systems, the company has achieved key regulatory milestones including FDA clearance and MDR-CE approval, positioning it for growth in the complex spine oncology market.

Proprietary BlackArmor® Carbon/PEEK (CF/PEEK) composite material platform for creating radiolucent, non-metallic spinal implants that enable unhindered radiation therapy and superior post-operative imaging.

icotec is the pioneer and market leader in radiolucent carbon/PEEK spinal implants for oncology, creating a distinct niche. It competes indirectly with large spine companies (e.g., Medtronic, Stryker, Johnson & Johnson) that offer traditional metallic implants, but its technology offers a unique value proposition for cases requiring post-op radiation. Barriers to entry include material science expertise and regulatory clearance.